Evidence map›Paper›PMID 35334353›Full record

ArticleEuropean journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society2022

Verbal learning and memory in youth with neurofibromatosis type 1 and plexiform neurofibromas: Relationships with disease severity.

Caitlyn Loucas, Pamela Wolters, Mary Anne Toledo-Tamula, Amanda Rhodes, Andrea Baldwin, Anne Goodwin, Brigitte Widemann, Staci Martin

Open access · greenAbstract read
In one paragraph

Article in European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Cells · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Caitlyn LoucasPediatric Oncology Branch, National Cancer Institute, Bethesda, MD, United States.
Pamela WoltersPediatric Oncology Branch, National Cancer Institute, Bethesda, MD, United States.
Mary Anne Toledo-TamulaClinical Research Directorate (CRD), Frederick National Laboratory for Cancer Research, United States.
Amanda RhodesPediatric Oncology Branch, National Cancer Institute, Bethesda, MD, United States.
Andrea BaldwinClinical Research Directorate (CRD), Frederick National Laboratory for Cancer Research, United States.
Anne GoodwinPediatric Oncology Branch, National Cancer Institute, Bethesda, MD, United States.
Brigitte WidemannPediatric Oncology Branch, National Cancer Institute, Bethesda, MD, United States.
Staci MartinPediatric Oncology Branch, National Cancer Institute, Bethesda, MD, United States. Electronic address: martins@mail.nih.gov.
National Cancer Institute · USFrederick National Laboratory for Cancer Research · US

Funding

Therapies for patients with rare tumors and genetic tumor predispositionZIASC010354 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI WIDEMANN, BRIGITTE · 2009 to 2025
$19.2M
Pediatric Oncology Branch Behvioral Science CoreZIDBC011517 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GLOD, JOHN · 2013 to 2025
$15.6M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZID BC011517NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

aimTo provide a comprehensive characterization of verbal learning and memory (VLM) abilities in youth with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PNs) and to evaluate disease severity as a predictor of VLM functioning over time.

methodAs part of a longitudinal natural history study, youth with NF1 and PNs were administered repeat neuropsychological assessments, including measures of VLM and ratings of NF1 disease severity completed by a medical professional. This sub-study analyzed data from 89 patients (M age

resultsVLM scores across the sample fell predominantly within the average range of functioning at both time points. However, relative to peers with mild NF1 disease severity, youth with moderate/severe NF1 disease showed lower functioning across multiple VLM domains at 36 months, even after controlling for the effects of verbal attention.

interpretationExclusive use of overall domain scores does not fully characterize VLM functioning in youth with NF1 and PNs. Additionally, children and adolescents with more severe NF1 disease should be monitored more closely for verbal memory challenges and targeted for interventions.

Indexed as

Neurofibroma, PlexiformNeurofibromatosis 1AdolescentChildChild, PreschoolHumansInfantNeuropsychological TestsSeverity of Illness IndexVerbal LearningNeurofibromatosis type 1 (NF1)Plexiform neurofibroma (PN)Verbal learning and memory

Identifiers

PMID35334353
PMCPMC10575344
OpenAlexW4221000738

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.